NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, Emma L. Barber, Kristin Bradley, Rebecca Brooks, Susana M. Campos, Junzo Chino, Hye Sook Chon, Marta A. Crispens, Shari Damast, Christine M. Fisher, Peter J. Frederick, David K. Gaffney, Stéphanie Gaillard, Robert Giuntoli, Scott Glaser, Jordan A. Holmes, Brooke E. Howitt, Jayanthi Lea, Gina Mantia-Smaldone, Andrea Mariani, David G. Mutch, Christa Nagel, Larissa Nekhlyudov, Mirna Podoll, Kerry J. Rodabaugh, Ritu Salani, John O. Schorge, Jean Siedel, Rachel Sisodia, Pamela T. Soliman, Stefanie Ueda, Renata R. Urban, Emily Wyse, Nicole R. McMillian, Shaili Aggarwal, Sara Espinosa
Abstract
The NCCN Guidelines for Cervical Cancer provide recommendations for all aspects of management for cervical cancer, including the diagnostic workup, staging, pathology, and treatment. The guidelines also include details on histopathologic classification of cervical cancer regarding diagnostic features, molecular profiles, and clinical outcomes. The treatment landscape of advanced cervical cancer is evolving constantly. These NCCN Guidelines Insights provide a summary of recent updates regarding the systemic therapy recommendations for recurrent or metastatic disease.